NDA 213536 · Dr Reddys Labs SA
Rezipres
Ephedrine Hydrochloride · Intravenous
DiscontinuedLast checked: Nov 20, 2026Latest source record: Jun 14, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2021
Jun 14, 2021
Approved uses
1
Original approval plus efficacy supplements
Registered trials
201
29 Phase 3, 14 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
4 products under this application
- REZIPRES · EPHEDRINE HYDROCHLORIDE 47MG/5ML (9.4MG/ML) · SOLUTION, INTRAVENOUS · Discontinued
- REZIPRES · EPHEDRINE HYDROCHLORIDE 23.5MG/5ML (4.7MG/ML) · SOLUTION, INTRAVENOUS · Discontinued
- REZIPRES · EPHEDRINE HYDROCHLORIDE 47MG/10ML (4.7MG/ML) · SOLUTION, INTRAVENOUS · Discontinued
- REZIPRES · EPHEDRINE HYDROCHLORIDE 47MG/ML (47MG/ML) · SOLUTION, INTRAVENOUS · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Ephedrine" as an intervention, any sponsor and status, largest first.
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Target Hemodynamics and Brain Injury During General Anesthesia in the ElderlyPivotal-lookingSuspended
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoAcademic, hospital or other
NCT02428062 · 1,812 participants (planned) · Start Oct 2014 · Primary completion Dec 2018
Drug: Phenylephrine; Intravenous fluids and 4 more · For: Post-operative Cognitive Dysfunction
Sites: Milan, Italy
- Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTIPivotal-lookingCompleted
Reckitt Benckiser Inc.Industry
NCT01202279 · 1,179 participants · Start Oct 2009 · Primary completion Apr 2010
Drug: Guaifenesin · For: Acute Upper Respiratory Track Infection
Sites: Mesa, Arizona; Carmichael, California; Fresno, California · 24 sites in all
- Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean SectionPivotal-lookingCompleted
Assiut UniversityAcademic, hospital or other
NCT02958215 · 980 participants · Start Jun 2016 · Primary completion May 2017
Drug: Phenylephrine · For: Anesthesia, Obstetrical; Anesthesia, Spinal
Sites: Asyut, Egypt
- Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac SurgeryPivotal-lookingRecruiting
Jagiellonian UniversityAcademic, hospital or other
NCT06885268 · 750 participants (planned) · Start Jun 24, 2025 · Primary completion Jun 30, 2027
Drug: noradrenaline infusion for management blood pressure · For: Blood Pressure Management; Intraoperative Hypotension; Non-cardiac Surgery
Sites: Katowice, Poland; Krakow, Poland; Olsztyn, Poland · 5 sites in all
- Prophylactic Ephedrine and Combined Spinal Epidurals for LaborPivotal-lookingCompleted
Sharp HealthCareAcademic, hospital or other
NCT02062801 · 710 participants · Start Jan 2012 · Primary completion Apr 2013
Drug: Ephedrine; Placebo · For: Labor Pain
Sites: San Diego, California
- HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal SurgeryPivotal-lookingCompleted
Humanitas Clinical and Research CenterAcademic, hospital or other
NCT05637606 · 636 participants · Start Mar 6, 2023 · Primary completion May 21, 2025
Drug: Ephedrine; Norepinephrine and 1 more · For: Blood Pressure; Complication,Postoperative; Intraoperative Hypotension
Sites: Foggia, Italy; Modena, Italy; Rome, Italy · 18 sites in all
- Phase 4 Study - Mucinex D as Adjunct TherapyPivotal-lookingCompleted
Adams Respiratory TherapeuticsIndustry
NCT00441246 · 600 participants (planned) · Start Feb 2007 · Primary completion May 2007
Drug: Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets) · For: Acute Respiratory Infection; Bronchitis; Rhinosinusitis
Sites: Birmingham, Alabama; Carmichael, California; Torrance, California · 28 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Early Use of Norepinephrine in High-risk Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial.
Trocheris-Fumery O, Flet T, Scetbon C, et al. · Anesthesiology 2025 · Randomized Controlled Trial
- [Not Available].
Kaabachi O, Nasri O, Raddaoui K, et al. · Tunis Med 2023 · Randomized Controlled Trial, English Abstract
- Ephedrine treatment for autoimmune myasthenia gravis.
Lipka AF, Vrinten C, van Zwet EW, et al. · Neuromuscul Disord 2017 · Randomized Controlled Trial
- Ephedrine- and guaifenesin-induced nephrolithiasis.
Bennett S, Hoffman N, Monga M · J Altern Complement Med 2004 · Systematic Review
- Cardiopulmonary effects of long-term bronchodilator administration.
Wilson AF, Novey HS, Cloninger P, et al. · J Allergy Clin Immunol 1976 · Clinical Trial, Comparative Study
- Prophylactic norepinephrine infusion to reduce severe hypotension during induction of anaesthesia in patients undergoing cardiac surgery: a randomised controlled single-centre clinical trial.
Gaillard C, Breul L, Foucher A, et al. · Br J Anaesth 2026 · Randomized Controlled Trial
Sponsor: Dr Reddys Labs SA
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.